Skip to content
10-Q

Quarterly Report

BioCrude Technologies USA, Inc.

0001731122-22-001853

← back to feed
Filed
Nov 4, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Sep 30, 2022 50.75M sh
Stockholders Equity Q3 2022 · Sep 30, 2022 −$191.03K
Stockholders Equity Q3 2022 · Dec 31, 2021 −$171.26K
Total Liabilities Q3 2022 · Sep 30, 2022 $212.34K
Total Liabilities Q3 2022 · Dec 31, 2021 $196.48K
Total Assets Q3 2022 · Sep 30, 2022 $18.73K
Total Assets Q3 2022 · Dec 31, 2021 $22.63K
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2021 $0
Revenue Q3 2022 · Sep 30, 2021 $0
Capex Q3 2022 · Sep 30, 2021 $92
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$298.8K
Sga Expense Q3 2022 · Sep 30, 2021 $45.88K
Sga Expense Q3 2022 · Sep 30, 2021 $360.73K
Operating Income Q3 2022 · Sep 30, 2021 −$45.88K
Operating Income Q3 2022 · Sep 30, 2021 −$360.73K